Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02776982 · ClinicalTrials.gov registry record · NA
Influence of Central Obesity on the Esophageal Epithelial Barrier
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02776982: Completed NA study, sponsored by Mayo Clinic.
NCT02776982 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02776982, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study is being done to help understand why some people with an increased amount of central obesity, without gastroesophageal reflux, develop changes to the lining of their esophagus that can potentially lead to esophageal adenocarcinoma (cancer).
Interventions
- PROCEDURE Confocal endomicroscopy
- PROCEDURE Mucosal impedance
- PROCEDURE Research biopsies
- PROCEDURE Bravo ambulatory pH monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-05-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02776982
The ClinicalTrials.gov registry entry for NCT02776982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Confocal endomicroscopy is the first listed.
NCT02776982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02776982 about?
NCT02776982 is a clinical study titled "Influence of Central Obesity on the Esophageal Epithelial Barrier". This study is being done to help understand why some people with an increased amount of central obesity, without gastroesophageal reflux, develop changes to the lining of their esophagus that can potentially lead to esophageal adenocarcinoma (cancer).
What is the current status of trial NCT02776982?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-11. Estimated completion is 2019-05-16.
What interventions are being tested in trial NCT02776982?
The interventions under investigation include: Confocal endomicroscopy (PROCEDURE), Mucosal impedance (PROCEDURE), Research biopsies (PROCEDURE), Bravo ambulatory pH monitor (PROCEDURE).
Who is sponsoring clinical trial NCT02776982?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.